Academic Commercialization Pipeline MCP Server

Academic commercialization intelligence for AI agents via the Model Context Protocol. This MCP server orchestrates 8 academic and patent data sources — OpenAlex, Semantic Scholar, ArXiv, USPTO, EPO, NIH Grants, Grants.gov, and ClinicalTrials.gov — to deliver a Commercialization Probability Score (0-100) composed from four independent scoring models: Research Momentum, Patent IP Strength, Funding Validation, and Technology Readiness Level (TRL) assessment.

Technology scouts, corporate venture teams, and tech transfer offices use this server to find spinout-ready research before competitors do. Rather than manually checking five databases, your AI agent calls a single tool and receives structured, scored intelligence within 90 seconds.

What data can you access?

Why use Academic Commercialization Pipeline MCP Server?

Manual technology scouting means opening five government databases, exporting CSVs, cross-referencing researcher names across patent and publication records, tracking grant histories, and then synthesizing findings into a coherent TRL assessment. A skilled analyst takes two to three days per technology area. Miss a patent filing or a Phase 2 trial announcement and the window for early-stage licensing closes.

This MCP server automates the entire pipeline. Your AI agent calls emerging_technology_radar once and receives a composite score derived from 8 live data sources in under two minutes. The scoring algorithms handle citation velocity calculation, author-to-inventor cross-referencing, SBIR grant trajectory analysis, and TRL keyword classification — returning a decision-ready verdict with supporting evidence signals.

Key platform benefits:

• Scheduling — run weekly technology radar scans via Apify Schedules to track how commercialization probability changes over time
• API access — trigger calls from Python, LangChain, CrewAI, or any HTTP client
• Proxy rotation — parallel actor calls handled by Apify's infrastructure without IP blocks
• Monitoring — get Slack or email alerts when runs fail via Apify webhooks
• Integrations — push scored results to Zapier, Make, Notion, or your CRM

Features

• 8 parallel data sources — OpenAlex, Semantic Scholar, ArXiv, USPTO, EPO, NIH Grants, Grants.gov, and ClinicalTrials.gov queried concurrently with a 120-second actor timeout per source
• 4 independent scoring models — Research Momentum (0-100), Patent Commercialization Signal (0-100), Funding Validation Index (0-100), and TRL Assessment (0-100) computed separately before compositing
• Weighted composite score — TRL carries 30% weight, Patent IP and Funding each 25%, Research Momentum 20%, reflecting empirical importance of late-stage signals
• 5-tier investment verdicts — INVEST_NOW, STRONG_CANDIDATE, MONITOR, TOO_EARLY, PASS — with an override rule: TRL 7+ combined with COMMERCIAL_READY IP status always escalates to INVEST_NOW
• Author-to-inventor cross-referencing — matches researcher surnames between OpenAlex authorships and USPTO/EPO inventor fields to detect publication-to-patent conversion
• Citation velocity calculation — computes average citations per paper and flags recency (post-2023 citations as a share of total) as a leading momentum indicator
• Momentum level classification — 5 tiers: DORMANT, EMERGING, ACCELERATING, HIGH_MOMENTUM, BREAKTHROUGH
• IP portfolio classification — 5 tiers: NO_IP, EARLY_FILING, PORTFOLIO_BUILDING, STRONG_IP, COMMERCIAL_READY
• Funding level classification — 5 tiers: UNFUNDED, SEED_STAGE, VALIDATED, WELL_FUNDED, TRANSLATION_STAGE
• TRL estimation from text — keyword analysis across patent abstracts and ArXiv papers classifies 9 high-TRL terms (commerc, manufactur, scale-up, fda approv), 6 mid-TRL terms (prototype, validat, feasib), and 3 low-TRL terms
• SBIR/STTR detection — identifies R43, R44, and STTR Phase II codes as high-weight commercialization signals, adding 5 points each to the NIH scoring component
• Clinical trial phase as TRL proxy — Phase 2 trials map to TRL 5-6, Phase 3 to TRL 7+, with phase number as a hard TRL floor override
• Evidence signals array — each scoring model returns plain-English signals (e.g., "6 granted patents — established IP portfolio") for agent reasoning chains
• Actionable recommendations — composite report includes specific next-step recommendations based on score profile gaps (e.g., "Strong TRL but weak IP — consider patent filing strategy")
• MCP Standby mode — server stays alive between requests, eliminating cold-start overhead for repeated queries
• Pay-per-event billing — charged only on successful tool calls; spending limits enforced per call to prevent runaway costs

Use cases for academic commercialization intelligence

Corporate venture technology sourcing

Corporate VC and M&A teams use this server to identify spinout-ready research before it becomes a known deal. The researcher_commercialization_signals tool detects when academic researchers begin converting publications into patents — typically 12-18 months before a formal spinout is announced. Running this scan across a target technology area weekly surfaces opportunities at the formation stage rather than after term sheets are circulating.

Tech transfer office pipeline management

Technology transfer officers use institution_innovation_profile to benchmark their commercialization pipeline against peer institutions. The tool pulls publication output, patent portfolio, and grant funding simultaneously and returns a structured profile showing which departments are generating strong IP signals versus which remain in basic research. Identify bottlenecks between publication and patent filing in a single query.

R&D build-vs-buy-vs-license strategy

Product strategy teams use emerging_technology_radar to assess whether a technology area is mature enough to license, early enough to develop internally, or at the right stage for an academic partnership. The TRL assessment (1-9) and funding trajectory tell you whether a technology has been validated by government funding or remains pre-commercial — the key distinction for licensing valuation.

Pharmaceutical partnership targeting

Pharma business development teams use clinical_translation_pipeline to track academic therapies moving through trial phases before Phase 2 results trigger competitive bidding. The tool cross-references ClinicalTrials.gov phases with NIH grant awards to identify which academic programs have both clinical traction and funding validation — the signature of acquisition-ready assets.

Patent landscape intelligence

IP strategy teams use patent_publication_crossref to map the IP landscape for a technology area before filing. The author-to-inventor cross-reference reveals which researchers are filing patents and with which assignees, giving insight into university licensing office strategies and potential freedom-to-operate issues. EPO coverage data indicates international filing intent.

Investor due diligence on deep tech

Deep tech investors use citation_velocity_analysis to validate whether a startup's technology claims are backed by genuine research momentum. A startup claiming breakthrough gene therapy innovation should have accelerating citations, recent preprints, and significant NIH grant backing. This tool surfaces that evidence in under a minute — before committing to a full diligence process.

How to use the Academic Commercialization Pipeline MCP Server

1. Connect the MCP server — Add the server URL to your MCP client configuration. For Claude Desktop, add https://academic-commercialization-pipeline-mcp.apify.actor/mcp under mcpServers. For other clients (Cursor, Windsurf, Cline), follow the same pattern.

2. Authenticate — Include your Apify API token as a Bearer token in request headers. You can find your token at console.apify.com/account/integrations.

3. Choose your tool — For a complete commercialization assessment, use emerging_technology_radar. For targeted analysis, use the focused tools: technology_breakthrough_scan for research signals, funding_flow_tracker for grant intelligence, or clinical_translation_pipeline for biomedical assets.

4. Receive structured results — Each tool returns a JSON response with scores, classification tiers, evidence signals, and supporting records (papers, patents, grants). Use the verdict field (INVEST_NOW, STRONG_CANDIDATE, MONITOR, etc.) to triage your pipeline.

MCP tools

Tool parameters

Connection examples

Claude Desktop (claude_desktop_config.json):

{
  "mcpServers": {
    "academic-commercialization-pipeline": {
      "url": "https://academic-commercialization-pipeline-mcp.apify.actor/mcp",
      "headers": {
        "Authorization": "Bearer YOUR_APIFY_TOKEN"
      }
    }
  }
}

Cursor / Windsurf / Cline (mcp.json):

{
  "mcpServers": {
    "academic-commercialization-pipeline": {
      "url": "https://academic-commercialization-pipeline-mcp.apify.actor/mcp",
      "headers": {
        "Authorization": "Bearer YOUR_APIFY_TOKEN"
      }
    }
  }
}

Direct HTTP (cURL):

curl -X POST "https://academic-commercialization-pipeline-mcp.apify.actor/mcp" \
  -H "Content-Type: application/json" \
  -H "Authorization: Bearer YOUR_APIFY_TOKEN" \
  -d '{
    "jsonrpc": "2.0",
    "method": "tools/call",
    "params": {
      "name": "emerging_technology_radar",
      "arguments": {
        "technology": "solid-state batteries",
        "sector": "energy storage"
      }
    },
    "id": 1
  }'

Usage from code

Python (with LangChain MCP adapter):

from langchain_mcp_adapters.client import MultiServerMCPClient

client = MultiServerMCPClient({
    "academic-commercialization": {
        "url": "https://academic-commercialization-pipeline-mcp.apify.actor/mcp",
        "transport": "streamable_http",
        "headers": {"Authorization": "Bearer YOUR_APIFY_TOKEN"},
    }
})

tools = await client.get_tools()
# Use emerging_technology_radar for full pipeline analysis
result = await client.call_tool(
    "emerging_technology_radar",
    {"technology": "solid-state batteries", "sector": "energy storage"}
)
print(result)

Python (raw HTTP):

import httpx, json

response = httpx.post(
    "https://academic-commercialization-pipeline-mcp.apify.actor/mcp",
    headers={
        "Content-Type": "application/json",
        "Authorization": "Bearer YOUR_APIFY_TOKEN",
    },
    json={
        "jsonrpc": "2.0",
        "method": "tools/call",
        "params": {
            "name": "technology_breakthrough_scan",
            "arguments": {"technology": "mRNA therapeutics"}
        },
        "id": 1,
    },
)
data = response.json()
momentum = data["result"]["content"][0]["text"]
parsed = json.loads(momentum)
print(f"Momentum: {parsed['researchMomentum']['momentumLevel']} ({parsed['researchMomentum']['score']}/100)")

JavaScript (raw HTTP):

const response = await fetch("https://academic-commercialization-pipeline-mcp.apify.actor/mcp", {
    method: "POST",
    headers: {
        "Content-Type": "application/json",
        "Authorization": "Bearer YOUR_APIFY_TOKEN",
    },
    body: JSON.stringify({
        jsonrpc: "2.0",
        method: "tools/call",
        params: {
            name: "funding_flow_tracker",
            arguments: { technology: "CRISPR gene editing" }
        },
        id: 1,
    }),
});

const data = await response.json();
const funding = JSON.parse(data.result.content[0].text);
console.log(`Funding level: ${funding.fundingValidation.fundingLevel}`);
console.log(`NIH grants: ${funding.fundingValidation.nihGrants}`);
console.log(`Clinical trials: ${funding.fundingValidation.clinicalTrials}`);

Output example

The emerging_technology_radar tool returns a full Commercialization Report. Example response for "solid-state batteries":

{
  "technology": "solid-state batteries",
  "compositeScore": 77,
  "verdict": "INVEST_NOW",
  "researchMomentum": {
    "score": 74,
    "citationVelocity": 41,
    "publicationCount": 28,
    "preprints": 9,
    "momentumLevel": "HIGH_MOMENTUM",
    "signals": [
      "High citation velocity (avg 41/paper) — strong research impact",
      "9 recent preprints — active research pipeline"
    ]
  },
  "patentCommerc": {
    "score": 82,
    "patentCount": 14,
    "grantedPatents": 6,
    "crossRefHits": 3,
    "commercLevel": "COMMERCIAL_READY",
    "signals": [
      "6 granted patents — established IP portfolio",
      "4 EPO filings — international patent strategy",
      "3 author-patent cross-references — researcher commercializing"
    ]
  },
  "fundingValidation": {
    "score": 79,
    "nihGrants": 0,
    "govGrants": 8,
    "clinicalTrials": 0,
    "fundingLevel": "WELL_FUNDED",
    "signals": []
  },
  "trlAssessment": {
    "score": 71,
    "estimatedTRL": 7,
    "trlLevel": "PILOT",
    "signals": [
      "Multiple commercialization keywords — advanced TRL indicators",
      "2 SBIR Phase II awards — commercialization validation"
    ]
  },
  "allSignals": [
    "High citation velocity (avg 41/paper) — strong research impact",
    "9 recent preprints — active research pipeline",
    "6 granted patents — established IP portfolio",
    "4 EPO filings — international patent strategy",
    "3 author-patent cross-references — researcher commercializing",
    "Multiple commercialization keywords — advanced TRL indicators",
    "2 SBIR Phase II awards — commercialization validation"
  ],
  "recommendations": [
    "Researcher-inventor overlap — strong commercialization intent"
  ]
}

Output fields

How much does it cost to run academic commercialization analysis?

This MCP server uses pay-per-event pricing — each tool call costs $0.045. Platform compute costs are included. All 8 tools are priced identically, including the full emerging_technology_radar which runs all 8 data sources in parallel.

You can set a maximum spending limit per session to control costs. The server enforces the limit per tool call and returns a clear error if the cap is reached.

Apify's free tier includes $5 of monthly platform credits — enough for over 100 individual tool calls or 100 full radar scans at no cost. Compare this to commercial patent intelligence platforms charging $500-2,000/month for database access alone.

How Academic Commercialization Pipeline MCP Server works

Parallel data collection

When a tool is called, the server dispatches concurrent requests to the relevant Apify actors using Promise.all. Each actor call is allocated 512 MB of memory and a 120-second timeout. The actor map connects tool logic to specific Apify actor IDs: openalex-research, semantic-scholar-search, patent-search, epo-patent-search, nih-research-grants, grants-gov-search, clinical-trial-tracker, and arxiv-paper-search. Failed actor calls return empty arrays and do not halt the scoring pipeline.

Research Momentum scoring

The momentum model draws from three sources. OpenAlex provides the citation velocity component (max 35 points): average citations per paper, with a 10-point bonus when post-2023 citations exceed 50% of total citations (indicating recent acceleration). Semantic Scholar provides the acceleration component (max 25 points): 3 points per paper with over 10 citations, plus 2 extra points per paper with over 3 influential citations. ArXiv provides the preprint velocity component (max 25 points): 3 points per recent preprint. A momentum amplifier (max 15 points) fires when high citation rates and preprint activity coincide. Final score maps to 5 levels: DORMANT (0-19), EMERGING (20-39), ACCELERATING (40-59), HIGH_MOMENTUM (60-79), BREAKTHROUGH (80-100).

Patent Commercialization Signal scoring

The patent model integrates three signals. USPTO data contributes up to 35 points: 4 points per granted patent, 2 per application, 2 per post-2022 patent. EPO data contributes up to 25 points based on B-type and A-type document kinds. The author-to-inventor cross-reference (max 25 points) extracts author surnames from OpenAlex authorships, then searches USPTO and EPO inventor/applicant/assignee fields for surname matches — 5 points per confirmed cross-reference hit. A recency bonus (max 15) rewards recent filings and dual USPTO/EPO coverage.

Funding Validation and TRL assessment

The funding model scores NIH grants (max 35): 3 points per grant, 4 per R01/R21/R35, 5 per SBIR/STTR. Grants.gov provides up to 25 points with bonus weighting for awards over $1M. ClinicalTrials.gov contributes up to 25 points: 4 per trial, 5 per Phase 2+ trial. The TRL model uses keyword analysis across patent and ArXiv text to classify technology maturity: 9 high-TRL keywords (commerc, manufactur, scale-up, fda approv, market, deploy, etc.) and 6 mid-TRL keywords (prototype, validat, feasib, proof of concept, preclinical) are scored against patent abstracts and ArXiv paper text. Clinical trial phase acts as a hard TRL floor: Phase 3 sets TRL to at least 7.

Composite score and verdict

The four model scores are weighted and summed: TRL (30%) + Patent (25%) + Funding (25%) + Momentum (20%). Verdicts are assigned at thresholds: INVEST_NOW (75+), STRONG_CANDIDATE (55-74), MONITOR (35-54), TOO_EARLY (15-34), PASS (0-14). One override rule applies: TRL score of 7+ combined with COMMERCIAL_READY IP status always produces an INVEST_NOW verdict regardless of composite score.

Tips for best results

1. Use emerging_technology_radar for initial screening. Run a full radar scan first to understand the composite picture. Then use focused tools like citation_velocity_analysis or patent_publication_crossref to drill deeper into specific signal dimensions.

2. Add sector context for better recall. Passing sector: "oncology" alongside technology: "CAR-T cell therapy" narrows OpenAlex and Semantic Scholar results to the relevant domain, improving signal quality in crowded research areas.

3. Track the same technology monthly. A single radar scan is a snapshot. Schedule monthly runs on the same query to track momentum trajectory. A technology moving from MONITOR to STRONG_CANDIDATE over 90 days is a stronger signal than a one-time high score.

4. Cross-validate researcher signals. If researcher_commercialization_signals returns cross-reference hits, follow up with patent_publication_crossref using the same researcher's name to see the full inventor-assignee chain. This reveals whether the researcher is filing under a university TTO or a personal company — a key diligence signal.

5. Use institution_innovation_profile for deal sourcing. Profile 10-20 research universities in your target sector quarterly. Institutions showing rising momentum + growing IP portfolios + SBIR activity are the likely sources of your next deal.

6. Interpret TRL in context. A TRL 3 in quantum computing means something different than TRL 3 in a therapeutics context. Review the trlAssessment.signals array for the specific evidence driving the TRL estimate before acting on the number alone.

7. Stack focused tools for targeted diligence. If your investment thesis hinges on IP protection, run patent_publication_crossref and researcher_commercialization_signals back to back. The overlapping evidence from two tools on the same query gives you higher confidence than a single composite score.

Combine with other Apify actors

Limitations

• No full-text access to paywalled papers. OpenAlex and Semantic Scholar return metadata and abstracts. Full-text analysis would require institutional subscriptions. TRL keyword analysis operates on title and abstract text only.
• Author name disambiguation is approximate. The cross-referencing system matches surnames and may miss inventors using initials or middle names. It may also produce false positives for common surnames. Use cross-reference hit counts as a directional signal, not a definitive match.
• Patent data reflects public filings only. Patents typically publish 18 months after filing. A technology with active private filings will understate its IP strength until those applications publish.
• Clinical trial data reflects registration, not results. A Phase 2 trial in the database means a trial was registered, not that it succeeded. The TRL model treats trial registration as a maturity signal; combine with citation_velocity_analysis to check whether publication results are positive.
• NIH grant data is US-centric. This server does not pull ERC (European Research Council), UKRI, or other international government grant data. Technologies primarily funded outside the US will understate their funding validation scores.
• ArXiv coverage is strongest in physics, math, computer science, and quantitative biology. Biomedical and clinical research preprints often use bioRxiv or medRxiv instead. Preprint velocity scores may undercount momentum in clinical domains.
• Typical response time is 30-120 seconds. The server queries 3-8 actors in parallel, each with their own network and processing latency. Do not use this server in latency-sensitive real-time applications.
• Emerging technology verdict is a screening tool, not a definitive assessment. The Commercialization Probability Score is designed to triage a large universe of technologies, not replace expert due diligence. Use it to prioritize which technologies deserve deeper investigation.

Integrations

• Zapier — trigger a technology radar scan when a new company enters your CRM pipeline and push the verdict and score back as deal fields
• Make — build automated weekly radar scans for a watchlist of technologies and route results to a Notion database or Google Sheet
• Google Sheets — export scored technology assessments into a tracking spreadsheet for portfolio management
• Apify API — call tools directly from Python or JavaScript pipelines for integration into proprietary deal flow platforms
• Webhooks — set alerts when the MCP server run completes so your downstream pipeline receives results without polling
• LangChain / LlamaIndex — register the MCP server as a tool set in an AI agent for autonomous technology scouting research workflows

Troubleshooting

• Low scores despite a known-active technology area — The scoring models depend on how research is indexed. Very new terms (coined in the last 6 months) may not yet appear in OpenAlex or Semantic Scholar with full citation data. Try alternate phrasings of the technology name or add a sector context parameter to improve recall. Also check whether the research is primarily published on bioRxiv rather than ArXiv, which would suppress preprint velocity scores.

• Cross-reference hits lower than expected — Author-to-inventor matching uses surname extraction from OpenAlex authorships. Researchers publishing under full names but patenting under initials (e.g., "Jennifer A. Doudna" vs. "J. Doudna") may not match. Run patent_publication_crossref with the researcher's last name only as the technology parameter to widen the inventor search.

• "Spending limit reached" error — Each tool call checks the actor's spending limit before executing. If you receive this error, increase the spending limit for this actor in your Apify account settings under Actor > Settings > Pay Per Event, or reduce the number of simultaneous tool calls in your agent.

• Timeout errors on emerging_technology_radar — The full radar calls 8 actors in parallel. In rare cases, one or more source actors may exceed their 120-second timeout. Failed sources return empty arrays and do not block scoring, but reduce score accuracy. Retry the call or use focused single-source tools to triangulate from available data.

• Institution profile returns empty signals — Some institution names have inconsistent spellings across databases (e.g., "UC Berkeley" vs. "University of California, Berkeley"). Try the full official institution name as it appears on grants.gov or the institution's own domain name. OpenAlex in particular uses standardized institution names from ROR identifiers.

Responsible use

• This MCP server only accesses publicly available academic databases, government grant registries, patent databases, and clinical trial records.
• All queried data sources (OpenAlex, USPTO, NIH, Grants.gov, ClinicalTrials.gov) are open-access government or non-profit infrastructure intended for research use.
• Use extracted researcher data in compliance with applicable privacy regulations. Do not use personal information from academic records for purposes beyond professional research and due diligence.
• Patent information is public by design. Citation and grant data are published for the purpose of advancing scientific transparency.
• For guidance on web scraping legality, see Apify's guide.

FAQ

How does the academic commercialization pipeline score work? The composite Commercialization Probability Score is a weighted average of four independent models: TRL Assessment (30%), Patent Commercialization Signal (25%), Funding Validation Index (25%), and Research Momentum Score (20%). Each model draws from different data sources and uses separate algorithms. A score above 75 triggers the INVEST_NOW verdict. One override rule applies: TRL 7+ combined with COMMERCIAL_READY IP always produces INVEST_NOW regardless of the composite.

How accurate is the author-to-inventor cross-referencing? The cross-reference extracts the last word from each author's display name (typically the surname) and searches for it in the inventor, applicant, and assignee fields of USPTO and EPO records. This approach catches the majority of matches but will miss inventors who patent under different name formats than they publish under, and may produce false positives for common surnames. Treat cross-reference hit counts above 2 as a strong directional signal rather than a definitive identification.

How current is the data returned by each tool? OpenAlex indexes daily and typically reflects citations within the past week. Semantic Scholar updates at a similar cadence. ArXiv preprints are indexed within 24 hours of submission. USPTO and EPO patent data is updated weekly. NIH Grants and Grants.gov data is updated as agencies report awards, typically within a few business days of a grant decision. Clinical trial data from ClinicalTrials.gov is updated as registrants submit changes.

Does the academic commercialization pipeline cover biotech and pharma specifically? Yes. The clinical_translation_pipeline tool is designed for biomedical research, pulling trial phases from ClinicalTrials.gov and NIH grant data simultaneously. The TRL model includes Phase 3 trial registration as a hard TRL 7+ floor. NIH scoring detects SBIR/STTR codes (R43, R44) that are specifically designed to fund commercialization of biomedical discoveries.

Can I schedule academic commercialization scans to run periodically? Yes. Use Apify Schedules to run the MCP server on a recurring basis. Because the server operates in Standby mode, it stays alive between requests, eliminating cold-start delays for scheduled queries. You can schedule weekly radar scans on a watchlist of technology areas and export results to a Google Sheet for trend tracking.

How is this different from commercial patent intelligence tools like PatSnap or Derwent? Commercial patent platforms provide deep patent analytics with full-text search, patent family trees, and citation graphs. This MCP server is designed for AI agent integration and composite multi-source scoring rather than standalone patent analytics. The key differentiator is the fusion of academic citation data, government grant flows, and clinical trial data into a single Commercialization Probability Score — a cross-domain signal not available in patent-only platforms. PatSnap costs $500-2,000/month; this server costs $0.045 per query.

What does the TRL score measure and how is it estimated? Technology Readiness Level (TRL) follows the NASA/DOE 1-9 scale. The server estimates TRL from three proxy signals: keyword analysis of patent and ArXiv abstracts (9 high-TRL keywords like "commercialization," "scale-up," and "FDA approved" versus 3 low-TRL keywords like "fundamental" and "hypothesis"), granted patent ratio (granted vs. applied), and clinical trial phase (Phase 2 = TRL 5-6, Phase 3 = TRL 7+). SBIR Phase II awards are also used as a TRL validation signal. The estimate is approximate — use clinical_translation_pipeline for higher-precision biomedical TRL assessment.

Is it legal to use academic publication data, patent data, and grant data this way? Yes. All data sources are public-access infrastructure: OpenAlex is an open-access database (CC0 license), USPTO and EPO data is public by statute, NIH grant data is published under the Freedom of Information Act, and ClinicalTrials.gov is operated by the US National Library of Medicine as a public registry. See Apify's guide on web scraping legality for broader context.

Can I use this MCP server in a multi-agent workflow? Yes. The server exposes standard MCP tools that any MCP-compatible orchestrator can call. It works with LangChain agent executors, CrewAI task agents, AutoGen, and any framework that supports the MCP protocol. Because it runs in Standby mode, the server maintains state between requests in a session, making it suitable for multi-step agent reasoning chains.

What happens if one of the 8 data sources is unavailable during a radar scan? Failed actor calls return empty arrays and do not halt the scoring pipeline. The composite score is computed from whichever sources successfully returned data. The result will be less accurate but will not error out. If a critical source fails repeatedly, check Apify's status page at status.apify.com and retry.

How long does a typical academic commercialization scan take? Focused tools querying 2-3 sources typically respond in 30-60 seconds. The emerging_technology_radar querying all 8 sources typically responds in 60-120 seconds. Actual time depends on source actor latency. The server runs all actor calls in parallel, so response time is bounded by the slowest individual source rather than the sum.

Can I use the academic commercialization scores in my own reporting tools? Yes. Each tool returns a structured JSON response that you can parse, store, and display in any reporting environment. All scores, classification levels, signals, and evidence records are included in the response. Export to Google Sheets, push to a BI tool, or embed in a deal management platform — the data is yours to use.

Help us improve

If you encounter issues, you can help us debug faster by enabling run sharing in your Apify account:

1. Go to Account Settings > Privacy
2. Enable Share runs with public Actor creators

This lets us see your run details when something goes wrong, so we can fix issues faster. Your data is only visible to the actor developer, not publicly.

Support

Found a bug or have a feature request? Open an issue in the Issues tab on this actor's page. For custom scoring models, additional data sources, or enterprise integration support, reach out through the Apify platform.